Invited Speaker

Osteoporosis and Bone Defects in Dentistry: New Drugs and Treatment Options
MAURO LABANCA
Italy

Osteoporosis, a skeletal disease characterized by reduction of bone mass and trabecular micro-architectural deterioration, is a major public health concern. So, we will analyze the most common therapies (biphosphonates, etc.) that are employed in this field and their side effects, like osteonecrosis of the jaw (ONJ); this can be useful since therapeutic strategies to improve or maintain bone health should further implemented.

Patients affected by osteoporosis and undergoing the biphosphonates therapy that should need oral surgery, implant treatment in particular, could be considered as more risky patients compared with normal patients.

We will verify if there are some safety precautions to take before treating these patients and if there are some procedures to avoid; considering the important rule that implant treatment should have nowaday for the quality of life of patients.

Finally, we will discuss if there are or will be present in the future on the market some specific drugs which would be able to increase the implant osteointegration and bone healing of patients affected by osteoporosis.